NYSE · LHHealthcareMedical Labs

Labcorp Holdings Inc. (LH)

$367.79+3.92%
Close Nov 4, 2026 · split-adjusted
Nov 2, 2026$355.59▲ 37.91% in range
Nov 3, 2025Low $246.64 · High $368.16Nov 2, 2026
What changed · written from our data
As of Nov 4, 2026

Labcorp Holdings closed at $367.79 on Nov 4, up 3.92%, 0.1% below its 52-week closing high. Volume of 809.7K shares was 1.08× its 20-day average (close to normal).

Split-adjusted performance: +18.0% over one month, +43.1% over six months, +42.6% over one year.

In the quarter ended Sep 30, 2026, revenue was $3.81B, up 6.9% from a year earlier, with a net margin of 6.9%.

Short interest was 2.6M shares at the Oct 15 settlement, down 4.7% from the prior report (3.4% of float, 4.2 days to cover).

Market cap$29.86B81.2M shares
Revenue · quarter$3.81B+6.9% YoY
Diluted EPS$3.22+3.2% YoY
P/E · TTM29.7×P/S 2.0×
Net margin6.9%Gross 29.1%
Dividend yield0.78%$0.72 last paid
52-week range246.64 – 368.16−0.1% from high
Volume809.7K1.08× 20-day avg
Volatility · 60d28.3%Annualised
Short % of float3.4%4.2 days to cover
Net cash-$5.66BCash $261.8M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.1%1M +18.0%3M +16.2%6M +43.1%YTD +46.6%1Y +42.6%3Y +85.6%5Y +52.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Medical Labs

Percentile among 24 companies (100 = best)

6-month momentum59
Revenue growth17
Net margin76
Value (low P/E)—
Size96

Industry medians: 6-month return +36.9%, revenue growth +25.0%, net margin −4.0%, P/E 32.4×.

Short interest

Details →
Shares short2.6M−4.7% vs prior
Days to cover4.2Settled Oct 15
% of float3.4%
Short vol. 10d46.3%of daily volume

Closest peers by size in Medical Labs

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
LHLabcorp Holdings$367.79+3.92%+43.1%+6.9%6.9%29.7$29.86B
DGXQuest Diagnostics$255.68+3.49%+35.2%+10.0%10.0%25.1$28.22BCompare
GHGuardant Health$168.58−3.67%+82.7%+44.3%−35.9%—$22.62BCompare
NTRANatera$391.03+0.62%+81.8%+37.7%−8.9%—$56.36BCompare
CAICaris Life Sciences$33.22+1.13%+73.7%+45.4%−0.2%89.3$9.39BCompare
GRALGRAIL$143.66+3.03%+128.9%+25.7%−246.7%—$6.42BCompare
RDNTRadNet$80.26+9.67%+36.9%+25.0%1.2%—$6.32BCompare
BLLNBillionToOne$113.89+3.11%+39.9%—7.4%—$5.37BCompare
CDNACareDx$85.86−2.95%+309.8%+39.3%13.8%35.1$4.51BCompare

Quick answers

What does Labcorp Holdings do?
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
What is LH's market cap?
$29.86B, based on the Nov 4 close of $367.79.
What is LH's P/E ratio?
29.7× trailing-twelve-month earnings of $1B.
Does Labcorp Holdings pay a dividend?
Yes. The latest regular dividend was $0.72 per share (ex-date Aug 28), an annualised yield of 0.78%.
How much of LH is sold short?
2.6M shares, 3.4% of float, as of Oct 15, 2026.
What sector is LH in?
Healthcare, in the Medical Labs industry.

About Labcorp Holdings

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

HQ: Burlington, NC71,000 employeesListed Jul 7, 1988labcorp.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology